Centessa Pharmaceuticals Plc (CNTA)
39.70
-0.06
(-0.16%)
USD |
NASDAQ |
Jun 10, 16:00
39.70
0.00 (0.00%)
After-Hours: 19:11
Centessa Pharmaceuticals Total Liabilities (Quarterly) : 154.42M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 154.42M |
| December 31, 2025 | 163.34M |
| September 30, 2025 | 146.73M |
| June 30, 2025 | 147.21M |
| March 31, 2025 | 141.60M |
| December 31, 2024 | 177.95M |
| September 30, 2024 | 110.58M |
| June 30, 2024 | 111.88M |
| March 31, 2024 | 113.01M |
| December 31, 2023 | 126.72M |
| September 30, 2023 | 117.97M |
| Date | Value |
|---|---|
| June 30, 2023 | 116.32M |
| March 31, 2023 | 110.60M |
| December 31, 2022 | 108.14M |
| September 30, 2022 | 106.43M |
| June 30, 2022 | 101.01M |
| March 31, 2022 | 102.04M |
| December 31, 2021 | 138.08M |
| September 30, 2021 | 63.07M |
| June 30, 2021 | 58.12M |
| March 31, 2021 | 41.89M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen, Inc. | 10.83B |
| Roivant Sciences Ltd. | 435.63M |
| Eli Lilly & Co. | 85.38B |
| Aptorum Group Ltd. | 4.900M |
| Bicycle Therapeutics Plc | 98.08M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 641.76M |
| Shareholders Equity (Quarterly) | 487.35M |
| Debt to Equity Ratio | 0.2433 |
| Current Ratio | 9.534 |
| Net Debt Paydown Yield | -0.00% |